SRSF2 P95H induces monocytic priming of human hematopoietic stem and progenitor cells
Authors:
Open Access
- 14 September 2026
- journal article
- letter
- Published by Springer Nature in Leukemia
- p. 1-5
Abstract
No abstract availableKeywords
Funding Information
- MEFOgraz
- Austrian Science Fund (PAT1753824)
- Austrian Science Fund (P36672)
- ERA-NET TRANSCAN-3 initiative
This publication has 14 references indexed in Scilit:
- Senescence and inflammation are unintended adverse consequences of CRISPR-Cas9/AAV6-mediated gene editing in hematopoietic stem cellsCell Reports Medicine, 2025
- SRSF2 plays an unexpected role as reader of m5C on mRNA, linking epitranscriptomics to cancerMolecular Cell, 2023
- The longitudinal dynamics and natural history of clonal haematopoiesisNature, 2022
- Coordinated alterations in RNA splicing and epigenetic regulation drive leukaemogenesisNature, 2019
- Synthetic Lethal and Convergent Biological Effects of Cancer-Associated Spliceosomal Gene MutationsCancer Cell, 2018
- Myeloid Disease Mutations of Splicing Factor SRSF2 Cause G2-M Arrest and Skewed Differentiation of Human Hematopoietic Stem and Progenitor CellsStem Cells, 2018
- Mapping the CLEC12A expression on myeloid progenitors in normal bone marrow; implications for understanding CLEC12A‐related cancer stem cell biologyJournal of Cellular and Molecular Medicine, 2018
- The Augmented R-Loop Is a Unifying Mechanism for Myelodysplastic Syndromes Induced by High-Risk Splicing Factor MutationsMolecular Cell, 2018
- SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon RecognitionCancer Cell, 2015
- Combining gene mutation with gene expression data improves outcome prediction in myelodysplastic syndromesNature Communications, 2015